HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 2,377: | Line 2,377: | ||
|6/30/24 | |6/30/24 | ||
|Pending | |Pending | ||
| ||SK|| || | |5/13/24||SK||6/6/24|| | ||
|Hepatosplenic T-cell Lymphoma | |Hepatosplenic T-cell Lymphoma | ||
|Michelle Don, MD, MS | |Michelle Don, MD, MS | ||
| Line 2,387: | Line 2,387: | ||
Sumire Kitahara, MD | Sumire Kitahara, MD | ||
| || ||Pending | |6/6/24|| ||Pending | ||
| ||SK|| || | | ||SK|| || | ||
|Anaplastic Large Cell Lymphoma, ALK-Positive | |Anaplastic Large Cell Lymphoma, ALK-Positive | ||
| Line 2,401: | Line 2,401: | ||
|[[HAEM5:ALK-negative anaplastic large cell lymphoma|ALK-negative anaplastic large cell lymphoma]]||Disease||Miguel Gonzalez Mancera, MD (trainee) | |[[HAEM5:ALK-negative anaplastic large cell lymphoma|ALK-negative anaplastic large cell lymphoma]]||Disease||Miguel Gonzalez Mancera, MD (trainee) | ||
Sumire Kitahara, MD | Sumire Kitahara, MD | ||
| || ||Pending | |6/6/24|| ||Pending | ||
| ||SK|| || | | ||SK|| || | ||
|Anaplastic Large Cell Lymphoma, ALK-Negative | |Anaplastic Large Cell Lymphoma, ALK-Negative | ||